Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Education and Workforce, and Ways and Means, for a period to be subsequently…
The No Harm Act prohibits federal funds from paying for, promoting, or supporting any “sex-trait altering treatment” for minors and blocks federal funding to institutions or states that allow such treatments without specified parental consent.
It requires parental informed consent (72-hour consultation and written consent), creates private causes of action for violations (including against the United States and states), expands civil and malpractice liability (including treble damages), protects conscience refusals by health providers, and adds a provision excluding gender change or affirmation from being considered “necessary to the health” under the female genital mutilation statute.
The bill defines covered treatments (puberty blockers, cross-sex hormones, many surgical procedures) and lists limited exceptions for disorders of sex development or emergent life‑threatening conditions.
Highly controversial, expands federal conditioning and private enforcement, lacks bipartisan compromise features; significant litigation and federalism risk reduce prospects.
Relative to its intended legislative type, this bill is a clearly focused substantive statute that is strong on definitional specificity and private enforcement mechanisms but limited in administrative implementation detail and fiscal acknowledgement.
Progressives emphasize harms to transgender youth and discrimination risk.
Progressives emphasize harms to transgender youth and discrimination risk.
This persona would view the bill as a sweeping federal restriction that would curtail medically recommended, evidence‑based care for transgender and gender‑diverse minors and stigmatize those youths.
They would be concerned it uses funding leverage and private litigation to limit access and could invite discriminatory treatment and legal challenges.
This persona would see the bill as addressing parental rights and certain safeguards but worry about federal overreach and unintended legal and medical consequences.
They would weigh desire for clear parental consent against concerns about blocking states’ medical judgments and creating large liability exposures.
This persona would likely support the bill as protecting children from irreversible medical interventions, reinforcing parental authority, and using federal funding levers to stop what they view as experimental treatments for minors.
They would also welcome conscience protections for providers.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Highly controversial, expands federal conditioning and private enforcement, lacks bipartisan compromise features; significant litigation and federalism risk reduce prospects.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize harms to transgender youth and discrimination risk.
Highly controversial, expands federal conditioning and private enforcement, lacks bipartisan compromise features; significant litigation an…
Relative to its intended legislative type, this bill is a clearly focused substantive statute that is strong on definitional specificity and private enforcement mechanisms but limited in administrative implementation de…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.